1. Home
  2. AYTU vs LGCB Comparison

AYTU vs LGCB Comparison

Compare AYTU & LGCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AYTU
    SELLHOLDBUYas of 11 hours ago
  • LGCB
    SELLHOLDBUYas of 11 hours ago
  • Stock Information
  • Founded
  • AYTU N/A
  • LGCB 2011
  • Country
  • AYTU United States
  • LGCB Japan
  • Employees
  • AYTU N/A
  • LGCB N/A
  • Industry
  • AYTU Biotechnology: Pharmaceutical Preparations
  • LGCB
  • Sector
  • AYTU Health Care
  • LGCB
  • Exchange
  • AYTU Nasdaq
  • LGCB Nasdaq
  • Market Cap
  • AYTU 8.3M
  • LGCB 8.4M
  • IPO Year
  • AYTU N/A
  • LGCB 2023
  • Fundamental
  • Price
  • AYTU $1.03
  • LGCB $0.16
  • Analyst Decision
  • AYTU
  • LGCB
  • Analyst Count
  • AYTU 0
  • LGCB 0
  • Target Price
  • AYTU N/A
  • LGCB N/A
  • AVG Volume (30 Days)
  • AYTU 37.5K
  • LGCB 449.6K
  • Earning Date
  • AYTU 05-14-2025
  • LGCB 04-15-2025
  • Dividend Yield
  • AYTU N/A
  • LGCB N/A
  • EPS Growth
  • AYTU N/A
  • LGCB N/A
  • EPS
  • AYTU N/A
  • LGCB N/A
  • Revenue
  • AYTU $77,232,000.00
  • LGCB $10,289,681.00
  • Revenue This Year
  • AYTU N/A
  • LGCB N/A
  • Revenue Next Year
  • AYTU $8.14
  • LGCB N/A
  • P/E Ratio
  • AYTU N/A
  • LGCB N/A
  • Revenue Growth
  • AYTU N/A
  • LGCB N/A
  • 52 Week Low
  • AYTU $0.97
  • LGCB $0.12
  • 52 Week High
  • AYTU $3.45
  • LGCB $5.71
  • Technical
  • Relative Strength Index (RSI)
  • AYTU 24.80
  • LGCB 39.01
  • Support Level
  • AYTU $1.20
  • LGCB $0.15
  • Resistance Level
  • AYTU $1.29
  • LGCB $0.17
  • Average True Range (ATR)
  • AYTU 0.07
  • LGCB 0.02
  • MACD
  • AYTU -0.01
  • LGCB -0.00
  • Stochastic Oscillator
  • AYTU 15.72
  • LGCB 56.93

Stock Price Comparison Chart: AYTU vs LGCB

AYTU
LGCB
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April020406080100120140160AYTU VS LGCB

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.

About LGCB Linkage Global Inc

Linkage Global Inc is a cross-border e-commerce integrated service provider. It provides international e-commerce merchants, overseas brands, import and export trading enterprises, etc. with a globally selected supply chain, digital marketing, e-commerce training, international store, ERP and e-commerce software, social e-commerce and other e-commerce integrated services. The Company has two operating segments: Extend from Japan, and Other Subsidiaries from Hong Kong. The company is Committed to building a one-stop cross-border integrated service platform to make cross-border trade easier. Company operates in Japan, Hong Kong and China, with maximum revenue from Japan.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use